Under The Microscope: Expert perspectives on personalised medicine in newly diagnosed advanced ovarian cancer
ESGO eAcademy. Presenters F. 10/23/21; 346484
Susana Banerjee
Andreas Du Bois
Thomas J. Herzog
REGULAR CONTENT
About this activity
Discussion Forum (0)
Chair: Andreas du Bois (Germany)
12:30-12:35 Chair’s welcome and introductions by Andreas du Bois (Germany)
12:35-12:50 Bringing BRCA into focus: Key considerations for implementing personalised medicine based on BRCA status by Susana Banerjee (United Kingdom)
12:50-13:05 Placing HRD under the lens: The role of genomic instability testing in optimising patient car by Thomas Herzog (USA)
13:05-13:10 Summary and meeting close by Andreas du Bois (Germany)
13:10-13:30 Panel discussion and Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
12:30-12:35 Chair’s welcome and introductions by Andreas du Bois (Germany)
12:35-12:50 Bringing BRCA into focus: Key considerations for implementing personalised medicine based on BRCA status by Susana Banerjee (United Kingdom)
12:50-13:05 Placing HRD under the lens: The role of genomic instability testing in optimising patient car by Thomas Herzog (USA)
13:05-13:10 Summary and meeting close by Andreas du Bois (Germany)
13:10-13:30 Panel discussion and Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}